Back to top

Image: Bigstock

Ameren (AEE) Q3 Earnings Top Estimates, 2018 Guidance Up

Read MoreHide Full Article

St. Louis, MO-based Ameren Corporation (AEE - Free Report) ) is a utility company, which generates and distributes electricity and natural gas to residential, commercial, industrial and wholesale end markets in Missouri and Illinois. The company serves nearly 2.4 million electric and more than 900,000 gas customers.

Ameren earnings were primarily driven by higher Ameren Missouri electric retail sales. Also, infrastructure investments made at Ameren Transmission, Ameren Illinois Electric Distribution contributed to bottom-line growth.

Estimates Revision & Earnings Surprise Trend

Investors should note that the third quarter Zacks Consensus Estimate for earnings of $1.25 per share has moved up to $1.28 per share over the last 30 days.

Ameren Corporation Price and EPS Surprise

Currently, Ameren has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Coming to the surprise, the company has reported positive earnings surprises in three of the last four quarters with an average positive earnings surprise of 9.76%.

We have mentioned below some of the vital information from this just-revealed announcement:

Earnings: Ameren’s third-quarter 2018 adjusted earnings were $1.50, which surpassed the Zacks Consensus Estimate of $1.28 per share.

Revenue: The company reported revenues of $1,724 million for the third-quarter, which increased 0.1% year over year owing to higher electric and natural gas sales volumes.

Key Stats to Note: Ameren has raised its 2018 earnings per share guidance to the range of $3.35-$3.45 from $3.15-$3.35 projected earlier.

Check back later for our full write up on this Ameren earnings report later!

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Ameren Corporation (AEE) - free report >>

Published in